Biopharmaceutical production method
US10457948B2 · kind B2 · utility
0Cited by
0References
7Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 6, 2015 |
| Grant date | Oct 29, 2019 |
| Priority date | — |
| Expiry date | Nov 6, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/034
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention resides in a method for the manufacture of a disulphide-requiring biopharmaceutical having an element of at least tertiary structure using wild type E. coli.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.